Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference27 articles.
1. Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis;Abudagga;Int J Chron Obstruct Pulmon Dis,2013
2. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study;Müllerová;BMJ Open,2014
3. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease;Solem;Int J Chron Obstruct Pulmon Dis,2013
4. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study;Celli;Am J Respir Crit Care Med,2008
5. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease;Donaldson;Thorax,2002
Cited by 352 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2024-10
2. A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-15
3. Therapeutische Implikationen der Diagnose „small airway disease“;Zeitschrift für Pneumologie;2024-08-13
4. The Real-World Efficacy of Fixed Triple Inhalation Therapy in the Treatment of Moderate COPD Patients (RATIONALE Study);International Journal of Chronic Obstructive Pulmonary Disease;2024-08
5. Adherence to single inhaler triple therapy and digital inhalers in Chronic Obstructive Pulmonary Disease: a literature review and protocol for a randomized controlled trial (TRICOLON study);BMC Pulmonary Medicine;2024-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3